Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

153.23 +1.30 (+0.86%)
Streaming Delayed Price Updated: 9:49 AM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Moderna Inc

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Moderna Announces Expansion of BARDA Agreement to Support Larger Phase 3 Program for Vaccine (mRNA-1273) Against COVID-19
Moderna announces expansion of BARDA agreement to support larger Phase 3 program for vaccine (mRNA-1273) against COVID-19. 
From Business Wire News Releases
Statement from Moderna on Patent Trial and Appeal Board (PTAB) Ruling
Statement from Moderna on Patent Trial and Appeal Board (PTAB) ruling. 
From Business Wire News Releases
Governments Around the World Escalate Precautions Amid the Surge
From InvestorBrandNetwork
Governments Around the World Escalate Precautions Amid the Surge
NetworkNewsWire Editorial Coverage 
From PR Newswire
Medidata Supports Moderna’s COVID-19 Vaccine Clinical Trials with Rave Clinical Cloud Platform
Medidata, a Dassault Systèmes company, the global leader in creating end-to-end solutions supporting the entire clinical trial process today announced that it is collaborating with Moderna, Inc.... 
From Business Wire News Releases
Data Shows Direct Link Between COVID-19 and Acute Respiratory Distress Syndrome (ARDS) In Infected Patients
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Data Shows Direct Link Between COVID-19 and Acute Respiratory Distress Syndrome (ARDS) In Infected Patients
Financialnewsmedia.com News Commentary 
From PR Newswire
Moderna to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020
Moderna to report second quarter 2020 financial results on Wednesday, August 5, 2020. 
From Business Wire News Releases
Thinking about buying stock in Denbury Resources, AstraZeneca, Just Energy Group, Sorrento Therapeutics, or Moderna?
InvestorsObserver issues critical PriceWatch Alerts for DNR, AZN, JE, SRNE, and MRNA. 
From PR Newswire
Novel Methods of Patient Monitoring Expand Diagnostic Capabilities
FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about trading options or stock in Moderna, Penn National Gaming, Tesla, United Airlines, or Costco Wholesale?
InvestorsObserver issues critical PriceWatch Alerts for MRNA, PENN, TSLA, UAL, and COST. 
From PR Newswire
Demand For Hand Sanitizers And Disinfectants Increasing as the Pandemic Concerns Grow
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Demand for Hand Sanitizers and Disinfectants Increasing as the Pandemic Concerns Grow
Financialnewsmedia.com News Commentary 
From PR Newswire
Flagship Pioneering Expands Executive Team with Appointment of Guillaume Pfefer as CEO-Partner
Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has further strengthened its executive leadership team with the appointment of life sciences industry veteran... 
From PR Newswire
Thinking about trading stock or options in Moderna Inc, Vaxart Inc, MGM Resorts, First Solar, or UnitedHealth Group?
InvestorsObserver issues critical PriceWatch Alerts for MRNA, VXRT, MGM, FSLR, and UNH. 
From PR Newswire
Distancing Measures Force Innovations in Patient Monitoring Procedures
FinancialBuzz.com News Commentary 
From PR Newswire
Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273)
Moderna announces publication of interim results from Phase 1 study of its mRNA vaccine against COVID-19 (mRNA-1273) in NEJM. 
From Business Wire News Releases
Thinking about trading options or stock in Overstock.com, Moderna, Alibaba, Boeing, or Ford?
InvestorsObserver issues critical PriceWatch Alerts for OSTK, MRNA, BABA, BA, and F. 
From PR Newswire
Moderna to Join the NASDAQ-100 Index Beginning July 20, 2020
Moderna to join the NASDAQ-100 Index beginning July 20, 2020. 
From Business Wire News Releases
Moderna, Inc. to Join the NASDAQ-100 Index Beginning July 20, 2020
From GlobeNewswire News Releases
Healthcare Practitioners Adapt to New Challenges with Innovative Devices
FinancialBuzz.com News Commentary 
From PR Newswire
Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
Moderna and ROVI announce collaboration for OUS fill finish manufacturing of Moderna’s COVID-19 vaccine candidate. 
From Business Wire News Releases
Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)
Moderna completes enrollment of Phase 2 study of its mRNA vaccine against COVID-19 (mRNA-1273). 
From Business Wire News Releases
Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing
Tessera Therapeutics emerges from three years of stealth operations to pioneer Gene Writing™ as a new genome engineering technology and category of genetic medicine 
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
From GlobeNewswire News Releases
Elizabeth Tallett Joins Moderna’s Board of Directors
Elizabeth Tallett joins Moderna’s Board of Directors. 
From Business Wire News Releases
Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
Moderna and Catalent announce collaboration for fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate. 
From Business Wire News Releases
Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, and... 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
From GlobeNewswire News Releases
Are Antivirals for COVID-19 More Likely To Be Developed And Approved Before A Vaccine
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.